Tailor an Options Trading Strategy to Fit Your Needs

From RJO Futures | Ad

This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.

Download your FREE Options Strategy Guide Today.

RXRX Insider Trading (Recursion Pharmaceuticals)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 22.25%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $9,865,609.03

Recursion Pharmaceuticals Insider Trading History Chart

Recursion Pharmaceuticals Share Price & Price History

^$8.43

▲ +0.29 (3.56%)

As of 07/1/2022 04:59 PM ET

Days: 30 | 90 | 365

Trading Isn’t Getting Easier–But Options Just Did!

From Tradewins | Ad

Options trading expert and trading champion Chuck Hughes has done it again with his guide, “Options Trading Made Easy”!

Made for new traders, this guide explains options–plus the consistent profits you could make–in easy to understand terms.

Don’t keep waiting for it to get easier–get the e-book here!

>>>

Recursion Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/2/2022	Christopher Gibson	CEO	Sell	39,690	$6.09	$241,712.10	516,268
5/4/2022	Christopher Gibson	CEO	Sell	31,830	$6.49	$206,576.70	511,972
4/28/2022	Christopher Gibson	CEO	Sell	37,605	$6.09	$229,014.45	469,608
4/21/2022	Christopher Gibson	CEO	Sell	37,155	$6.31	$234,448.05	420,146
4/18/2022	Christopher Gibson	CEO	Sell	35,836	$6.84	$245,118.24	394,791
4/14/2022	Christopher Gibson	CEO	Sell	34,517	$7.56	$260,948.52	368,117
4/7/2022	Christopher Gibson	CEO	Sell	36,718	$6.54	$240,135.72	314,534
4/5/2022	Christopher Gibson	CEO	Sell	34,472	$7.43	$256,126.96	288,742
3/14/2022	Christopher Gibson	CEO	Sell	230,000	$6.28	$1,444,400.00
3/11/2022	Christopher Gibson	CEO	Sell	100,000	$6.95	$695,000.00
3/7/2022	Christopher Gibson	CEO	Sell	300,000	$7.30	$2,190,000.00
2/22/2022	Christopher Gibson	CEO	Sell	100,000	$10.22	$1,022,000.00
1/31/2022	Christopher Gibson	CEO	Sell	19,858	$11.73	$232,934.34
1/13/2022	Christopher Gibson	CEO	Sell	87,000	$14.33	$1,246,710.00
1/4/2022	Blake Borgeson	Director	Sell	9,625	$18.03	$173,538.75
12/21/2021	Blake Borgeson	Director	Sell	9,625	$18.75	$180,468.75
12/16/2021	Christopher Gibson	CEO	Sell	200	$20.00	$4,000.00
12/16/2021	Tina Marriott Larson	COO	Sell	2,500	$18.74	$46,850.00
12/13/2021	Christopher Gibson	CEO	Sell	100	$20.02	$2,002.00
12/9/2021	Christopher Gibson	CEO	Sell	1,086	$20.01	$21,730.86
12/7/2021	Blake Borgeson	Director	Sell	9,625	$20.32	$195,580.00
12/7/2021	Christopher Gibson	CEO	Sell	3,125	$20.51	$64,093.75
11/19/2021	Dean Y. Li	Director	Sell	13,474	$20.20	$272,174.80
11/18/2021	Tina Marriott Larson	COO	Sell	2,500	$18.92	$47,300.00
11/17/2021	Dean Y. Li	Director	Sell	5,626	$20.04	$112,745.04

Tailor an Options Trading Strategy to Fit Your Needs

From RJO Futures | Ad

This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.

Download your FREE Options Strategy Guide Today.

SEC Filings (Institutional Ownership Changes) for Recursion Pharmaceuticals (NASDAQ:RXRX)

55.25% of Recursion Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Recursion Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/30/2022	Amalgamated Bank	17,187	$0.12M	0.0%	-7.3%	0.010%
6/7/2022	Bank of America Corp DE	83,680	$0.60M	0.0%	-51.1%	0.049%
5/27/2022	Walleye Capital LLC	30,882	$0.22M	0.0%	N/A	0.018%
5/17/2022	Walleye Capital LLC	30,882	$0.22M	0.0%	N/A	0.018%
5/17/2022	Jane Street Group LLC	13,967	$100K	0.0%	-22.7%	0.008%
5/17/2022	Royal Bank of Canada	7,081	$51K	0.0%	-71.5%	0.004%
5/16/2022	California State Teachers Retirement System	84,397	$0.60M	0.0%	-12.4%	0.049%
5/16/2022	Goldman Sachs Group Inc.	209,409	$1.50M	0.0%	+69.4%	0.123%
5/16/2022	Pinz Capital Management LP	142,168	$1.02M	0.6%	N/A	0.083%
5/16/2022	State Street Corp	1,918,734	$13.74M	0.0%	-58.8%	1.124%
5/16/2022	Engineers Gate Manager LP	82,120	$0.59M	0.0%	N/A	0.048%
5/16/2022	Cresset Asset Management LLC	47,017	$0.34M	0.0%	-64.8%	0.028%
5/16/2022	UBS Group AG	6,927	$49K	0.0%	-97.3%	0.004%
5/13/2022	Renaissance Technologies LLC	178,400	$1.28M	0.0%	N/A	0.104%
5/13/2022	Northern Trust Corp	859,544	$6.15M	0.0%	-3.0%	0.503%
5/13/2022	Charles Schwab Investment Management Inc.	373,164	$2.67M	0.0%	-1.1%	0.219%
5/13/2022	Lazard Asset Management LLC	188,924	$1.35M	0.0%	+31.8%	0.111%
5/13/2022	Mariner LLC	28,119	$0.20M	0.0%	N/A	0.016%
5/13/2022	American International Group Inc.	57,225	$0.41M	0.0%	-6.6%	0.034%
5/13/2022	Vanguard Group Inc.	6,611,377	$47.34M	0.0%	+8.1%	3.872%
5/13/2022	Platinum Investment Management Ltd.	2,136,604	$15.30M	0.5%	+48.0%	1.251%
5/12/2022	BlackRock Inc.	6,707,757	$48.03M	0.0%	-0.8%	3.928%
5/12/2022	Rhumbline Advisers	123,892	$0.89M	0.0%	+4.0%	0.073%
5/12/2022	Metropolitan Life Insurance Co NY	7,689	$55K	0.0%	-74.8%	0.005%
5/12/2022	MetLife Investment Management LLC	64,035	$0.46M	0.0%	+55.4%	0.037%
5/12/2022	Artal Group S.A.	450,000	$3.22M	0.1%	+125.0%	0.264%
5/12/2022	Citigroup Inc.	14,899	$0.11M	0.0%	-93.9%	0.009%
5/11/2022	Bank of New York Mellon Corp	373,700	$2.68M	0.0%	+1.7%	0.219%
5/11/2022	Massachusetts Financial Services Co. MA	1,336,750	$9.57M	0.0%	+2.8%	0.783%
5/11/2022	JPMorgan Chase & Co.	127,039	$0.91M	0.0%	-18.8%	0.074%
5/10/2022	ProShare Advisors LLC	38,107	$0.27M	0.0%	-20.0%	0.022%
5/10/2022	TD Asset Management Inc.	32,534	$0.23M	0.0%	-36.7%	0.019%
5/10/2022	CNA Financial Corp	28,672	$0.21M	0.1%	+11.2%	0.017%
5/9/2022	Swiss National Bank	94,300	$0.68M	0.0%	+7.6%	0.055%
5/9/2022	Manchester Capital Management LLC	13,440	$96K	0.0%	N/A	0.008%
5/6/2022	Nikko Asset Management Americas Inc.	415,268	$2.82M	0.0%	+12.5%	0.243%
5/6/2022	GoalFusion Wealth Management LLC	54,000	$0.39M	0.3%	N/A	0.032%
5/5/2022	Baillie Gifford & Co.	21,981,604	$157.39M	0.1%	-0.6%	12.872%
5/5/2022	New York State Common Retirement Fund	80,420	$0.58M	0.0%	+19.1%	0.047%
5/4/2022	Hamilton Lane Advisors LLC	15,225	$0.11M	0.0%	-43.9%	0.009%
5/4/2022	Titleist Asset Management LTD.	37,550	$0.27M	0.1%	-50.4%	0.022%
4/29/2022	Daiwa Securities Group Inc.	7,241	$52K	0.0%	+41.6%	0.004%
4/21/2022	Strs Ohio	14,600	$0.10M	0.0%	-35.4%	0.009%
4/19/2022	Foundations Investment Advisors LLC	23,524	$0.18M	0.0%	+50.7%	0.014%
4/19/2022	ARK Investment Management LLC	2,827,163	$20.24M	0.1%	+26.7%	1.655%
2/15/2022	MV Management XI L.L.C.	1,971,908	$33.78M	14.6%	N/A	1.167%
2/15/2022	Seven Eight Capital LP	26,001	$0.45M	0.1%	N/A	0.015%
2/15/2022	Samsara BioCapital LLC	539,236	$9.24M	1.8%	-28.4%	0.319%
2/15/2022	Kemnay Advisory Services Inc.	121,573	$2.08M	0.3%	N/A	0.072%
2/15/2022	MIC Capital Management UK LLP	1,388,889	$23.79M	4.6%	N/A	0.822%
2/14/2022	Itau Unibanco Holding S.A.	2,530	$44K	0.0%	N/A	0.001%
2/14/2022	Virtus ETF Advisers LLC	8,821	$0.15M	0.1%	N/A	0.005%
2/14/2022	Mission Creek Capital Partners Inc.	111,850	$1.92M	0.4%	N/A	0.066%
2/14/2022	Alliancebernstein L.P.	2,875,819	$49.26M	0.0%	+75.4%	1.702%
2/14/2022	Credit Suisse AG	1,559,618	$26.72M	0.0%	+7.5%	0.923%
2/14/2022	State Street Corp	4,656,727	$79.77M	0.0%	+183.2%	2.756%
2/14/2022	Rockefeller Capital Management L.P.	10,397	$0.18M	0.0%	+407.2%	0.006%
2/11/2022	CNA Financial Corp	25,782	$0.44M	0.1%	+56.0%	0.015%
2/11/2022	Ensign Peak Advisors Inc	15,470	$0.27M	0.0%	N/A	0.009%
2/11/2022	Pentwater Capital Management LP	280,000	$4.80M	0.1%	+5.7%	0.166%
2/10/2022	Rhumbline Advisers	119,074	$2.04M	0.0%	+370.9%	0.070%
2/10/2022	Spouting Rock Asset Management LLC	90,203	$1.55M	1.2%	+70.7%	0.053%
2/10/2022	Rafferty Asset Management LLC	395,134	$6.77M	0.0%	+480.9%	0.234%
2/10/2022	Citigroup Inc.	244,357	$4.19M	0.0%	+439.5%	0.145%
2/10/2022	TD Asset Management Inc.	51,434	$0.88M	0.0%	+26.6%	0.030%
2/10/2022	Massachusetts Financial Services Co. MA	1,300,041	$22.27M	0.0%	+45.1%	0.769%
2/10/2022	Allen Operations LLC	217,657	$3.73M	0.5%	+219.6%	0.129%
2/9/2022	Principal Financial Group Inc.	35,471	$0.61M	0.0%	N/A	0.021%
2/9/2022	Lazard Asset Management LLC	143,384	$2.46M	0.0%	N/A	0.085%
2/9/2022	Alps Advisors Inc.	184,614	$3.16M	0.0%	N/A	0.109%
2/9/2022	Evoke Wealth LLC	4,480	$77K	0.0%	N/A	0.003%
2/9/2022	Mitsubishi UFJ Trust & Banking Corp	373,390	$6.40M	0.0%	-6.3%	0.221%
2/8/2022	Bank of America Corp DE	171,175	$2.93M	0.0%	+545.8%	0.101%
2/8/2022	Swiss National Bank	87,600	$1.50M	0.0%	N/A	0.052%
2/8/2022	Handelsbanken Fonder AB	13,300	$0.23M	0.0%	N/A	0.008%
2/8/2022	Nikko Asset Management Americas Inc.	368,994	$6.32M	0.0%	-9.8%	0.218%
2/8/2022	ProShare Advisors LLC	47,649	$0.82M	0.0%	N/A	0.028%
2/8/2022	Northern Trust Corp	885,961	$15.18M	0.0%	+253.4%	0.524%
2/7/2022	SG Americas Securities LLC	22,842	$0.39M	0.0%	+86.2%	0.014%
2/7/2022	American Century Companies Inc.	303,051	$5.19M	0.0%	+100.2%	0.179%
2/7/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	14,957	$0.27M	0.0%	N/A	0.009%
2/4/2022	Arizona State Retirement System	10,700	$0.18M	0.0%	N/A	0.006%
2/3/2022	Daiwa Securities Group Inc.	5,114	$88K	0.0%	N/A	0.003%
2/2/2022	New York State Common Retirement Fund	67,517	$1.16M	0.0%	+368.8%	0.040%
2/2/2022	Clarius Group LLC	13,600	$0.23M	0.0%	N/A	0.008%
2/2/2022	DekaBank Deutsche Girozentrale	35,000	$0.59M	0.0%	N/A	0.021%
2/2/2022	Sumitomo Mitsui Trust Holdings Inc.	368,994	$6.32M	0.0%	-9.8%	0.218%
2/1/2022	Zurcher Kantonalbank Zurich Cantonalbank	16,065	$0.28M	0.0%	+105.3%	0.010%
2/1/2022	Assenagon Asset Management S.A.	10,179	$0.17M	0.0%	N/A	0.006%
1/31/2022	CWM LLC	4,510	$77K	0.0%	N/A	0.003%
1/28/2022	Hamilton Lane Advisors LLC	27,123	$0.47M	0.1%	N/A	0.016%
1/28/2022	ARK Investment Management LLC	2,232,013	$38.23M	0.1%	-13.9%	1.321%
1/24/2022	Strs Ohio	22,600	$0.39M	0.0%	+242.4%	0.013%
1/21/2022	Foundations Investment Advisors LLC	15,606	$0.23M	0.0%	+52.3%	0.009%
1/21/2022	Russell Investments Group Ltd.	34,166	$0.58M	0.0%	+8.3%	0.020%
1/20/2022	Baillie Gifford & Co.	22,123,155	$378.97M	0.2%	+0.3%	13.091%
1/14/2022	Baldwin Brothers LLC MA	2,751	$47K	0.0%	N/A	0.002%
12/8/2021	Moors & Cabot Inc.	25,000	$28K	0.0%	N/A	0.015%
11/16/2021	Laurion Capital Management LP	3,923,713	$90.29M	0.4%	+1.7%	2.329%
11/16/2021	Metropolitan Life Insurance Co NY	8,134	$0.19M	0.0%	+22.0%	0.005%

Data available starting January 2016

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 to treat familial adenomatous polyposis; and REC-3599, which is in Phase I clinical trial to treat GM2 gangliosidosis. Its preclinical stage product includes REC-3964 to treat Clostridium difficile colitis; REC-64917 for the treat of neural or systemic inflammation; REC-65029 to treat HRD-negative ovarian cancer; REC-648918 to enhance anti-tumor immune; REC-2029 for the treatment of wnt-mutant hepatocellular carcinoma; REC-14221 to treat solid and hematological malignancies; and REC-64151 for the treatment of immune checkpoint resistance in KRAS/STK11 mutant non-small cell lung cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Today's Range

Now: $8.43

$8.14

$8.86

50 Day Range

MA: $6.67

$5.04

$9.26

52 Week Range

Now: $8.43

$4.92

$42.81

Volume

67,240 shs

Average Volume

1,122,317 shs

Market Capitalization

$1.44 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Recursion Pharmaceuticals?: Recursion Pharmaceuticals' top insider investors include:
Christopher Gibson (CEO)
Blake Borgeson (Director)
Dean Y Li (Director)
Mubadala Investment Co Pjsc (Major Shareholder)
Tina Marriott Larson (COO)
Learn More about top insider investors at Recursion Pharmaceuticals.

Being A Successful Trader Just Got Easier…